{
  "id": 14182339,
  "title": "Apogee execs join Paragon to scale its R&D, company creation engine",
  "url": "https://urgent.news/2026/10/13/apogee-execs-join-paragon-to-scale-its-r-d-company-creation-engine",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-13T11:00:35.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/apogee-execs-join-paragon-to-scale-its-rd-company-creation-engine/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Some people would think about taking a break for several quarters after selling a biotech for $10.9 billion. Michael Henderson and five of his fellow executives from Apogee Therapeutics are not fading ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}